ReviewCancer management and research2023
Drug-Resistance Mechanism and New Targeted Drugs and Treatments of Relapse and Refractory DLBCL.
Jing Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
35 papers cite it
this paperpooled itcites it